Shay Capital LLC

Source: SEC Form 13F · as of Mar 2026

Shay Capital LLC holds 44 biotech & pharma companies tracked by BioSniper, totaling $22.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

44

Total value held

$22.4M

CompanySharesValue
QGENQIAGEN N.V.42,672$1.7M
VKTXViking Therapeutics, Inc.47,900$1.6M
QUREuniQure N.V.94,327$1.5M
APGEApogee Therapeutics, Inc.16,500$1.4M
SRRKScholar Rock Holding Corp28,000$1.4M
BCAXBicara Therapeutics Inc.63,500$1.3M
RVMDREVOLUTION MEDICINES, INC.12,000$1.2M
MANEVeradermics Incorporated18,000$1.1M
ELVElevance Health Inc.3,000$878K
OSCROscar Health Inc.74,837$858K
NUVLNuvalent, Inc.8,275$848K
DNTHDianthus Therapeutics, Inc. /DE/9,500$797K
NUVBNuvation Bio Inc.175,056$751K
ACHVACHIEVE LIFE SCIENCES, INC.205,114$603K
ATAIAtai Beckley N.V.164,142$581K
OKUROnKure Therapeutics, Inc.132,219$547K
HALOHALOZYME THERAPEUTICS, INC.8,000$517K
RXRXRECURSION PHARMACEUTICALS, INC.159,841$491K
APLSApellis Pharmaceuticals, Inc.10,347$416K
MDXHMDxHealth SA150,000$345K
ALMSALUMIS INC.15,000$330K
DNAGinkgo Bioworks Holdings Inc.50,229$308K
TRDAEntrada Therapeutics, Inc.21,548$272K
CYTKCYTOKINETICS INC3,275$216K
CTMXCytomX Therapeutics, Inc.45,000$212K
ATONAlphaTON Capital Corp612,300$193K
DFTXDefinium Therapeutics Inc.10,000$189K
TLPHTALPHERA, INC.250,083$187K
CHRSCoherus Oncology, Inc.105,326$178K
BHVNBiohaven Ltd.20,025$169K
SPROSpero Therapeutics, Inc.70,354$165K
GUTSFractyl Health Inc.357,865$164K
CMPSCOMPASS Pathways plc27,600$153K
AVTXAvalo Therapeutics, Inc.10,166$152K
CRONCronos Group Inc.47,298$119K
HUMAHumacyte Inc.173,020$105K
IMAImageneBio, Inc.19,130$96K
UPBUpstream Bio, Inc.10,000$90K
VTGNVistagen Therapeutics, Inc.144,452$83K
OABIOmniAb Inc.49,662$78K
ALTSALT5 Sigma Corp50,558$56K
ANNXAnnexon, Inc.10,000$55K
ZNTLZentalis Pharmaceuticals, Inc.10,662$25K
BMEABiomea Fusion, Inc.10,000$15K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Shay Capital LLC — Biotech 13F Holdings & Portfolio | BioSniper